I have been told I have Thyroid Eye Disease (TED) and have been reading about a new treatment just approved in the USA called Teprotumumab or Tepezza which appears to be very successful in treating TED.
I also read, that it is in Phase II Clinical trials in the UK and Phase III in the EU (sps.nhs.uk/medicines/teprot... and have been trying to find out when that might be approved for patients in the UK (or EU).
Does anyone have any knowledge of the NHS approval phases, how long they take and when this drug might become available? Are we far behind the US - ie. have we just started trials or have the trials been taking place for the past 2 years?
Just curious - as it sounds like it's very effective treatment.